ACLS
Axcelis Technologies, Inc.
ACLS's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over ACLS overall, supported by stronger valuation and stronger fundamentals.
ACLS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
ACLS's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
ACLS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $48.20 | -55% |
| Forward | 18x | $108 | — |
| Fair | 22x | $73.95 | -32% |
| Current | 32x | $108 | — |
| Expensive | 34x | $113 | +4.9% |
Historical ranges are pointers, not guarantees.
ACLS's PE is in its expensive range at 32x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over ACLS in the historical PE scenario, which offers more potential upside but is not a forecast.
ACLS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
ACLS has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
ACLS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.05 | +80% |
| Q3 2026 | $3.37 | -20% |
| Q2 2026 | $2.99 | -39% |
| Q1 2026 | $3.22 | -41% |
| Q4 2025 | $3.80 | -38% |
| Q3 2025 | $4.23 | -37% |
| Q2 2025 | $4.89 | -33% |
| Q1 2025 | $5.46 | -28% |
| Q4 2024 | $6.15 | -17% |
ACLS's earnings per share have fallen from their peak: $3.37 over the past year, against $7.57 in early 2024.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over ACLS on earnings, with more consistent year-over-year improvement.
ACLS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $237.8M | +11% |
| Q2 2026 | $215.2M | +11% |
| Q1 2026 | $199M | +3.3% |
| Q4 2025 | $238.3M | -5.6% |
| Q3 2025 | $213.6M | -17% |
| Q2 2025 | $194.5M | -24% |
| Q1 2025 | $192.6M | -24% |
| Q4 2024 | $252.4M | -19% |
ACLS's revenue is recovering but still below its 2023 peak: $238M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -0.2 points |
| Q2 2026 | 9.4% | -5.5 points |
| Q1 2026 | 4% | -11 points |
| Q4 2025 | 15% | -6.4 points |
| Q3 2025 | 12% | -6.6 points |
| Q2 2025 | 15% | -5.7 points |
| Q1 2025 | 15% | -7.3 points |
| Q4 2024 | 22% | -3.9 points |
ACLS's operating margin was 12% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over ACLS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over ACLS on profitability, with a higher operating margin.
ACLS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $37.7M | -13% |
| Q2 2026 | $14.8M | -61% |
| Q1 2026 | $16.3M | -53% |
| Q4 2025 | -$8.9M | -210% |
| Q3 2025 | $43.3M | +3.6% |
| Q2 2025 | $37.7M | -0.8% |
| Q1 2025 | $34.8M | -14% |
| Q4 2024 | $8.1M | -85% |
ACLS still generates free cash flow, though less than at its 2022 peak: $60M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over ACLS on cash flow, with more consistent year-over-year improvement.
ACLS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -29K shares |
| 1 year | -1.1% | -345K shares |
| 3 years | -6.2% | -2.1M shares |
| 5 years | -8.8% | -3M shares |
| Available history | -8% | -2.7M shares |
ACLS has the edge over NVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2025 | $25.2M |
| Q3 2025 | $32.3M |
| Q2 2025 | $45.3M |
| Q1 2025 | $18.2M |
| Q4 2024 | $15.1M |
| Q3 2024 | $15.4M |
| Q2 2024 | $15M |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has 24.3B diluted shares, down 1% from a year ago, with $55.3B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
ACLS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.7x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.2x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
ACLS has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ACLS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 23.9 | Neutral |
ACLS's weekly RSI is 44 (neutral) and its Stochastic is 24 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
ACLS PE vs Technology Sector
| Metric | ACLS | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 28x | 15% above |
| PE % | 82 | 35 | 47 pts above |
ACLS is trading at 32x earnings, a 15% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over ACLS on valuation relative to its sector.
ACLS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $116.0 | 6.8% below |
| 20 week MA | $123.9 | 13% below |
| 50 week MA | $117.7 | 8.2% below |
| 100 week MA | $93.6 | 15% above |
| 200 week MA | $110.6 | 2.3% below |
ACLS's trend is mixed: it's above one of its five weekly moving averages, and 2.3% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
ACLS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.2 | $29.2 | +21% |
| 2021 | $29.2 | $68.1 | +133% |
| 2022 | $68.1 | $80.3 | +18% |
| 2023 | $80.3 | $129.7 | +62% |
| 2024 | $129.7 | $71.2 | -45% |
| 2025 | $71.2 | $82.6 | +16% |
| 2026 YTD | $82.6 | $108.1 | +31% |
ACLS has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.